Izun Oral Care is proud to announce the results of an open-label study utilizing PerioPatch in the management of acute peri-implantitisPosted On Apr 01 th Comment
Izun Oral Care is proud to announce the results of an open-label study utilizing PerioPatch in the management of acute peri-implantitis. Peri-implantitis is an enormous and growing oral care problem that affects up to 36% of dental implants and can lead to significant pain, bleeding and swelling of peri-implant tissues (soft and hard), leading in many cases to the eventual loss of the implant. Peri-implantitis is a complex condition with symptoms very similar to that of gum disease. Until recently, most treatment interventions have focused on the infectious disease nature of these conditions. However, it is now becoming increasingly clear that protecting the inflamed gums around the implant can play a key role for successful treatments outcomes in peri-implant disease.
PerioPatch is a topical patch designed as adjunctive therapy to provide site-specific protection while promoting the gingival tissue’s natural healing capacity. The data suggest that by protecting the gum tissue around the implant from further irritation and removing the inflammatory exudate results in rapid reduction in swelling and pain. Indeed, it should be emphasized that for this study, PerioPatch was used as the sole therapy to treat the inflamed gums and mucosal tissue surrounding the dental implant in 18 patients (with a total of 23 dental implant sites) without any debridement or antimicrobial treatment.
PerioPatch was applied to the affected areas twice daily for three days (total of 6 patches over the treatment period). Patients were evaluated at baseline and in a follow-up time point - four days after completion of the treatment. The baseline and follow-up data were compared.
The results demonstrate a rapid and clinically meaningful reduction in inflamed or bleeding gums and probing depth at treated sites, as well as a significant reduction in the presence of pathogenic bacteria.
The results support the novel concept that PerioPatch can play an important role in the management of peri-implantitis.